Intuitive Surgical (ISRG) CMO’s trust sells 526 shares after awards vest
Rhea-AI Filing Summary
Intuitive Surgical (ISRG) executive Myriam Curet reported option exercises, RSU vesting, and related share sales through a trust. On February 10, 2026, a trust associated with Curet acquired 838 common shares from vested RSUs and 105 shares via stock option exercise, and disposed of 417 shares to cover taxes. The trust also sold 105 shares at $494.65 on February 10 and 421 shares at $494.96 on February 11 in open-market transactions under a Rule 10b5-1 trading plan. Following these transactions, the trust held 409 common shares, while Curet directly held derivative positions including 1,257 stock options and 838 RSUs subject to the disclosed vesting schedules.
Positive
- None.
Negative
- None.
Insights
Routine equity vesting and planned sales by a trust linked to ISRG’s CMO.
These transactions show Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, managing existing equity awards. RSUs vested into 838 common shares and 105 option shares were exercised, with part of the stock withheld to satisfy tax obligations.
The trust associated with Curet then executed open-market sales of 105 and 421 shares at prices around $494 per share. A key detail is that the sales followed a Rule 10b5-1 trading plan that expires on July 29, 2026, indicating they were pre-arranged rather than discretionary.
After the trades, the trust held 409 shares, while derivative holdings included 1,257 options and 838 RSUs with time-based vesting from February 10, 2023. Overall, this appears to be standard equity compensation activity rather than a signal of a strategic shift.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 421 | $494.96 | $208K |
| Exercise | Non-Qualified Stock Option (right to buy) | 105 | $0.00 | -- |
| Exercise | Restricted Stock Units | 838 | $0.00 | -- |
| Exercise | Common Stock | 838 | $0.00 | -- |
| Tax Withholding | Common Stock | 417 | $492.84 | $206K |
| Exercise | Common Stock | 105 | $229.39 | $24K |
| Sale | Common Stock | 105 | $494.65 | $52K |
Footnotes (1)
- RSUs vest 25% per year over a four year period, commencing on each anniversary of February 10, 2023. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026. 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock upon vesting. 25% of the RSUs shall vest on each anniversary of February 10, 2023, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
